S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
Log in
NASDAQ:RYTM

Rhythm Pharmaceuticals News Headlines

$25.98
+0.48 (+1.88 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.85
Now: $25.98
$26.15
50-Day Range
$25.50
MA: $31.07
$39.49
52-Week Range
$12.99
Now: $25.98
$43.26
Volume553,716 shs
Average Volume488,812 shs
Market Capitalization$1.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.57

Headlines

Rhythm Pharmaceuticals (NASDAQ RYTM) News Headlines Today

Source:
SourceHeadline
Zacks Investment Research Upgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) to HoldZacks Investment Research Upgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) to Hold
marketbeat.com - March 5 at 4:33 AM
Morgan Stanley Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $53.00Morgan Stanley Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $53.00
marketbeat.com - February 25 at 11:16 AM
Morgan Stanley Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $57.00Morgan Stanley Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $57.00
americanbankingnews.com - March 3 at 11:01 AM
Rhythm Pharmaceuticals (NASDAQ:RYTM) Releases Quarterly  Earnings Results, Beats Expectations By $0.01 EPSRhythm Pharmaceuticals (NASDAQ:RYTM) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS
americanbankingnews.com - March 2 at 10:54 AM
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial ResultsRhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 1 at 9:22 AM
Zacks: Brokerages Anticipate Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) to Post -$0.81 Earnings Per ShareZacks: Brokerages Anticipate Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) to Post -$0.81 Earnings Per Share
americanbankingnews.com - February 28 at 8:38 AM
CEO: How Rhythm Energy stayed open when other retailers went darkCEO: How Rhythm Energy stayed open when other retailers went dark
bizjournals.com - February 26 at 6:26 PM
Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Raised to $53.00 at Morgan StanleyRhythm Pharmaceuticals (NASDAQ:RYTM) PT Raised to $53.00 at Morgan Stanley
americanbankingnews.com - February 25 at 12:26 PM
Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care ConferenceRhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference
finance.yahoo.com - February 24 at 8:34 AM
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $53.00Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $53.00
americanbankingnews.com - February 18 at 8:57 AM
What Kind Of Investors Own Most Of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)?What Kind Of Investors Own Most Of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)?
finance.yahoo.com - February 12 at 2:22 PM
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesRhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 10 at 7:17 PM
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public OfferingRhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
finance.yahoo.com - February 4 at 11:51 PM
Stock Alert: Rhythm Pharma Shares Gains On Positive Phase 2 DataStock Alert: Rhythm Pharma Shares Gains On Positive Phase 2 Data
nasdaq.com - January 26 at 3:01 PM
Why Is It Moving? Looking Into Why Rhythm Pharmaceuticalss Stock is Trading Higher TodayWhy Is It Moving? Looking Into Why Rhythm Pharmaceuticals's Stock is Trading Higher Today
msn.com - January 26 at 3:01 PM
Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R Pathway Deficiency-related ObesitiesRhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R Pathway Deficiency-related Obesities
finance.yahoo.com - January 26 at 9:25 AM
Eladio Carrión Secures Second Top 10 on Latin Rhythm Albums Chart With MonarcaEladio Carrión Secures Second Top 10 on Latin Rhythm Albums Chart With 'Monarca'
msn.com - January 21 at 2:51 PM
Rhythm Pharmaceuticals to Provide Update on Phase 2 Basket Study and Genetic Sequencing EffortsRhythm Pharmaceuticals to Provide Update on Phase 2 Basket Study and Genetic Sequencing Efforts
finance.yahoo.com - January 19 at 7:01 PM
Pharvaris Expands Board of Directors with Appointment of David Meeker, M.D., as Chair and Robert Glassman, M.D., as DirectorPharvaris Expands Board of Directors with Appointment of David Meeker, M.D., as Chair and Robert Glassman, M.D., as Director
finance.yahoo.com - January 5 at 9:39 AM
Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100MRhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M
finance.yahoo.com - January 5 at 9:39 AM
Global Circadian Rhythm Sleep Disorder Market 2020 Key Business Opportunities, Impressive Growth Rate and Development Analysis to 2025Global Circadian Rhythm Sleep Disorder Market 2020 Key Business Opportunities, Impressive Growth Rate and Development Analysis to 2025
marketwatch.com - December 23 at 5:06 AM
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström SyndromesRhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
finance.yahoo.com - December 22 at 7:28 AM
Rhythm Pharmaceuticals IncRhythm Pharmaceuticals Inc
bloomberg.com - December 15 at 11:06 PM
Police Investigating After At Least Three People Shot Outside Whiskey Rhythm BarPolice Investigating After At Least Three People Shot Outside Whiskey Rhythm Bar
msn.com - December 12 at 1:44 PM
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of DirectorsRhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
finance.yahoo.com - December 11 at 9:05 AM
Is RYTM A Good Stock To Buy Now?Is RYTM A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 5:51 PM
Rhythm (RYTM) Up on FDA Approval of Weight Management DrugRhythm (RYTM) Up on FDA Approval of Weight Management Drug
finance.yahoo.com - November 30 at 5:35 PM
Rhythm Pharmaceuticals’ IMCIVREE Gets FDA Stamp of Approval; Stifel Boosts Price TargetRhythm Pharmaceuticals’ IMCIVREE Gets FDA Stamp of Approval; Stifel Boosts Price Target
finance.yahoo.com - November 29 at 5:06 PM
How This Small Biotech Is Targeting Obesity — And Why Shares Are SurgingHow This Small Biotech Is Targeting Obesity — And Why Shares Are Surging
finance.yahoo.com - November 27 at 5:21 PM
FDA OKs Rhythm Pharmas Imcivree for weight management in obese patientsFDA OKs Rhythm Pharma's Imcivree for weight management in obese patients
seekingalpha.com - November 27 at 8:43 AM
Rhythm Pharma Announces FDA Approval Of IMCIVREE - Quick FactsRhythm Pharma Announces FDA Approval Of IMCIVREE - Quick Facts
nasdaq.com - November 27 at 8:43 AM
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR DeficiencyRhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
finance.yahoo.com - November 27 at 8:43 AM
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial ResultsRhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 2 at 8:24 AM
Flawless Real Talk from Rhythm + Flow connects with fans through LIVITFlawless Real Talk from Rhythm + Flow connects with fans through LIVIT
msn.com - October 30 at 3:31 PM
Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North AmericaRhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America
finance.yahoo.com - October 28 at 9:53 AM
We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business GrowthWe Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth
finance.yahoo.com - October 20 at 5:38 PM
$26.8 Billion Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2025 with Abbott Labs, Medtronic and Boston Scientific Dominating ...$26.8 Billion Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2025 with Abbott Labs, Medtronic and Boston Scientific Dominating ...
businesswire.com - October 15 at 9:01 AM
Rhythm Pharmaceuticals (RYTM) Looks Good: Stock Adds 5.1% in SessionRhythm Pharmaceuticals (RYTM) Looks Good: Stock Adds 5.1% in Session
nasdaq.com - October 9 at 2:25 PM
Viewers React To Mohales Debut On Rhythm CityViewers React To Mohale's Debut On Rhythm City
msn.com - October 1 at 2:17 PM
Rhythm Pharmaceuticals to Present at Investor Conferences in SeptemberRhythm Pharmaceuticals to Present at Investor Conferences in September
finance.yahoo.com - September 9 at 9:52 AM
Global Cardiac Rhythm Management (CRM) Devices IndustryGlobal Cardiac Rhythm Management (CRM) Devices Industry
finance.yahoo.com - September 5 at 8:28 AM
Bristol Rhythm & Roots Reunion live stream lineup announcedBristol Rhythm & Roots Reunion live stream lineup announced
msn.com - September 3 at 12:11 AM
Rhythm (RYTM) Soars: Stock Adds 9.4% in SessionRhythm (RYTM) Soars: Stock Adds 9.4% in Session
finance.yahoo.com - September 1 at 1:04 PM
Global Cardiac Rhythm Management (CRM) Market 2020 With COVID-19 Update, Industry Segmentation, CAGR Status, Leading Trends, and Forecast To 2026Global Cardiac Rhythm Management (CRM) Market 2020 With COVID-19 Update, Industry Segmentation, CAGR Status, Leading Trends, and Forecast To 2026
marketwatch.com - August 10 at 8:49 AM
Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth ConferenceRhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
finance.yahoo.com - August 6 at 10:09 AM
Rhythm Pharmaceuticals EPS beats by $0.12Rhythm Pharmaceuticals EPS beats by $0.12
seekingalpha.com - August 3 at 9:58 AM
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial ResultsRhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 3 at 9:58 AM
Rhythm Pharmaceuticals Announces Appointment of Joseph Shulman as Senior Vice President of Technical OperationsRhythm Pharmaceuticals Announces Appointment of Joseph Shulman as Senior Vice President of Technical Operations
finance.yahoo.com - July 27 at 11:06 AM
Global Cardiac Rhythm Management Device Market 2020 Development Analysis, Strategic Outlook, Growth Rate and Forecast to 2025Global Cardiac Rhythm Management Device Market 2020 Development Analysis, Strategic Outlook, Growth Rate and Forecast to 2025
www.marketwatch.com - July 22 at 11:47 PM
Rhythm Pharma names new CEORhythm Pharma names new CEO
seekingalpha.com - July 20 at 1:37 PM
Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive OfficerRhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer
finance.yahoo.com - July 20 at 8:36 AM
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide in Bardet-Biedl Syndrome in Diabetes, Obesity and MetabolismRhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide in Bardet-Biedl Syndrome in Diabetes, Obesity and Metabolism
finance.yahoo.com - July 16 at 8:36 AM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.